Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Difficile Associated Diarrhea (CDAD)”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Large-scale testing (Phase 3)Study completedNCT00958308
What this trial is testing

Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial Infection

Who this might be right for
Antibiotic-Associated DiarrheaClostridium Difficile-Associated Diarrhea
Bio-K Plus International Inc. 255
Large-scale testing (Phase 3)Ended earlyNCT00466635
What this trial is testing

Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea

Who this might be right for
Enterocolitis, PseudomembranousDiarrheaClostridium Difficile
Genzyme, a Sanofi Company 65
Large-scale testing (Phase 3)Study completedNCT00182429
What this trial is testing

Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment

Who this might be right for
Clostridium EnterocolitisAntibiotic-Associated DiarrheaPseudomembranous Colitis+2 more
McMaster University 100
Early research (Phase 1)Study completedNCT02835105
What this trial is testing

Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008)

Who this might be right for
Clostridium Difficile Associated Diarrhea (CDAD)
Merck Sharp & Dohme LLC 40
Testing effectiveness (Phase 2)Study completedNCT00097422
What this trial is testing

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Diarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Early research (Phase 1)Study completedNCT02835118
What this trial is testing

Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)

Who this might be right for
Clostridium Difficile Associated Diarrhea (CDAD)
Merck Sharp & Dohme LLC 30
Large-scale testing (Phase 3)Study completedNCT02218372
What this trial is testing

Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
Astellas Pharma Europe B.V. 148
Large-scale testing (Phase 3)Study completedNCT00269399
What this trial is testing

A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Clostridium InfectionsDiarrhea
Bausch Health Americas, Inc. 237
Post-approval studies (Phase 4)WithdrawnNCT00304863
What this trial is testing

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

Who this might be right for
EnterocolitisPseudomembranous ColitisAntibiotic-associated Colitis
Michael E. DeBakey VA Medical Center
Large-scale testing (Phase 3)Study completedNCT01691248
What this trial is testing

Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001)

Who this might be right for
Clostridium Difficile-Associated Diarrhea (CDAD)
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 611
Not applicableStudy completedNCT01401023
What this trial is testing

Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)

Who this might be right for
DiarrheaClostridium Difficile
Gary E. Stein, Pharm.D. 10
Large-scale testing (Phase 3)Ended earlyNCT03105479
What this trial is testing

Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile Infection
Actelion 1
Large-scale testing (Phase 3)Ended earlyNCT01143272
What this trial is testing

Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea

Who this might be right for
Antibiotic-associated DiarrheaClostridium DifficileDiarrhea
Bernhard Nocht Institute for Tropical Medicine 477
Post-approval studies (Phase 4)Ended earlyNCT00177970
What this trial is testing

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
University of Pittsburgh 14
Large-scale testing (Phase 3)Study completedNCT00314951
What this trial is testing

Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 629
Not applicableWithdrawnNCT01596153
What this trial is testing

Probiotics in Hospitalized Patients Study

Who this might be right for
Antibiotic Associated DiarrheaClostridium Difficile Associated Diarrhea
South Shore Hospital
Testing effectiveness (Phase 2)Study completedNCT03824795
What this trial is testing

Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD

Who this might be right for
Clostridium Difficile Infection
MGB Biopharma Limited 34
Not applicableUnknownNCT02681068
What this trial is testing

MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation

Who this might be right for
Clostridium Infections
University of Cologne 1,000
Testing effectiveness (Phase 2)Study completedNCT01925417
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Who this might be right for
Recurrent Clostridium Difficile Infection
Rebiotix Inc. 34
Post-approval studies (Phase 4)Ended earlyNCT04003818
What this trial is testing

Efficacy and Safety of Teicoplanin in CDAD

Who this might be right for
Clostridium Difficile Infection-associated Diarrhea and Colitis
Sanofi 50
Load More Results